By modulating inflammatory responses, immune cell recruitment, and cell survival, NF-κB fosters a pro-tumorigenic microenvironment that enables osteosarcoma cells to evade immune surveillance and resist conventional therapies. The gene discussed is NFKB1; the disease is osteosarcoma.